The United States is on the brink of losing its measles elimination status, a distinction it has held since 2000, as an independent commission of the Pan American Health Organization (PAHO) conducts a critical review in Washington, D.C. Experts anticipate the country will lose the designation, marking a significant setback in public health.
The review, spanning from November 10 through Friday, focuses on whether the virus has maintained continuous endemic transmission within the U.S. for 12 months. According to PAHO’s criteria, the test is genetic; the committee examines whether the same virus lineage has circulated uninterrupted for a year or more.
Measles elimination means no strain spreads here nonstop for 12 months. The U. S. reached it in 2000. This week, a PAHO panel reviews it. Johns Hopkins counts 5,400 cases in 2026. Save and send to a parent: https://t.co/VHt4y9dbbM Read & subscribe for free:… pic.twitter.com/Uve67kOxeR
If the panel concludes that transmission has been continuous, the U.S. will join Canada as the only other country in the region to have lost control of the virus.
The current outbreak is the worst in more than three decades. The Centers for Disease Control and Prevention (CDC) has reported 5,182 confirmed cases nationwide as of early November 2026. This figure represents a dramatic increase from the 2,289 cases recorded throughout 2025 and the 285 cases in 2024.
“.. experts convening on Tuesday to decide whether the United States should lose its official designation as a nation that has eliminated measles.”@nytimes https://t.co/YAozbJwKeU pic.twitter.com/PtWLnjXHqQ
Health departments have attributed at least eight deaths to these outbreaks, including an infant in Wisconsin—the state’s first measles-related fatality since 1990. Hospitalization rates for the 2026 surge are approximately 6%, though historical data suggests typical yearly rates often fluctuate between 11% and 12%.
Paul Rota, who spent 40 years at the CDC and managed its measles lab, expressed a blunt assessment of the situation on This Week in Virology, noting that there is very little that can be done to alter the outcome of the current review.
PAHO's commission is meeting this week on whether the US keeps its measles elimination status. The US had 85 cases the year it eliminated measles in 2000. This year it's past 5,100. It may come down to sequencing, whether outbreaks across states trace to one lineage for 12… pic.twitter.com/R9lZIsJTmX
However, he emphasized that the status is “recoverable.” Brazil serves as a potential roadmap for restoration; after losing its elimination status in 2019, the country regained it in 2024 by implementing targeted vaccination campaigns and enhancing disease surveillance.
Economic consequences of the outbreak are substantial. CNBC reports that 2025 outbreaks, which involved 2,289 confirmed cases, carried an economic burden exceeding $37 million. When analyzing the broader impact, experts point to a “ripple effect” where contact-tracing requirements and mandatory quarantines drive up costs even for those who do not contract the disease.
Each person quarantined is estimated to result in roughly $300 in lost productivity. If a single case exposes 40 to 50 people, the resulting economic impact grows rapidly due to the labor-intensive nature of public health responses.
Maintaining protection against the virus requires a 95% vaccination rate; however, CDC data shows that 92.4% of kindergartners were vaccinated in 2026, down from 95.2% in 2020. Vaccination coverage is inconsistent, with 18 states reporting rates below 90%. Idaho, for instance, has reported a rate of 75.2%.
Michael Osterholm, an expert in the field, warns that these numbers fail to capture the full extent of the crisis, as vaccination rates can vary wildly within states, leaving hyper-local pockets of unprotected individuals.
Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, characterized the potential loss of status as a formality, stating, “Measles is back.”
My comments with @ABC @MaryKekatos about meetings this week to examine America’s measles elimination statushttps://t.co/QxvE5wulz0
Public health officials continue to stress that the MMR vaccine is safe, effective, and the most reliable method for prevention. Two doses are 97% effective at preventing infection. Because measles can manifest with symptoms similar to other respiratory infections—including cough and runny nose—medical professionals advise individuals to consult with a qualified provider to discuss vaccination eligibility and to monitor for symptoms if exposure is suspected.
Earlier coverage: US measles cases reach 35-year high, CDC says
